Study Investigates Steroid Use in Inflammatory Bowel Disease

Understanding Inflammatory Bowel Disease

Inflammatory bowel disease (IBD) is a chronic inflammatory condition affecting the digestive tract, encompassing Crohn’s disease and ulcerative colitis. Patients typically require lifelong treatment, with steroids commonly prescribed to manage flare-ups. However, excessive use of steroids can lead to adverse effects and poor health outcomes.

Frequency and Avoidability of Steroid Overuse

A recent study published in Alimentary Pharmacology & Therapeutics focused on the overuse of steroids in patients with inflammatory bowel disease. Researchers aimed to assess how often steroids were used excessively and to explore measures for improving care quality. The study involved 2,385 patients from 19 centers throughout the UK, some of which had previously participated in a quality improvement initiative.

Using a straightforward computer program, the researchers conducted an in-depth evaluation of patient cases to reduce steroid overuse. All participants had a confirmed diagnosis of IBD and had lived with the condition for at least three months. Data were gathered to identify instances of steroid dependency or overuse within the past year. Patients were classified as overusers if they received steroids for more than three months, underwent multiple treatment courses, or experienced a recurrence of symptoms shortly after treatment.

The findings revealed that 14.8% of patients qualified as steroid overusers. Notably, about half of these cases were deemed avoidable. Additionally, centers that implemented the quality improvement program exhibited lower rates of steroid overuse, although patients with moderate to severe ulcerative colitis were an exception. The study indicated a correlation between disease severity and increased steroid use but did not analyze variables such as age, sex, or disease duration.

Importance of the Study

As knowledge about inflammatory bowel disease evolves, the standards of care remain inconsistent compared to other medical conditions. This study highlights the potential for measuring steroid overuse in clinical settings through a simple computer program. Such measurements could play a crucial role in enhancing care standards, improving patient outcomes, and optimizing healthcare services.

References

Selinger, Christian P. et al. Assessment Of Steroid Use As A Key Performance Indicator In Inflammatory Bowel Disease-Analysis Of Data From 2385 UK Patients. Alimentary Pharmacology and Therapeutics. 2019 March 24;00:1-10. doi: 10.1111/apt.15497.
Are steroids used too much for patients with inflammatory bowel disease?. 9 Oct 2019. https://www.eurekalert.org/pub_releases/2019-10/w-asu100819.php.
Image by silviarita from Pixabay.